Clinical Trial Update: Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2b study evaluating cetuximab with platinum-based chemotherapy as first-line treatment for recurrent or advanced non-small cell lung cancer. Results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Accelerated Community Oncology Research Network | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-10-11